The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats.
The present study showed a novel finding that the development of adjuvant-induced arthritis (AA) in Lewis rats was completely prevented by incomplete Freund's adjuvant (IFA) injected 21 or 28 days before complete Freund's adjuvant (CFA) challenge. Hexadecane also completely prevented AA and squalane, methyl oleate and pristane moderately prevented AA, though pristane by itself induced mild arthritis in two out of five rats. Concanavalin A-stimulated lymph node cells (LNCs) isolated from AA rats were able to adoptively transfer the severe polyarthritis to all the naive recipients or even to the IFA pretreated recipients with earlier onset and more rapid progression than those of AA. The LNCs from the donors who had been pretreated with IFA and subsequently challenged with CFA could induce mild arthritis in only two out of eight naive recipients, whereas all the recipients who were challenged with CFA immediately after intravenous injection of these LNCs developed significantly less severe arthritis. However, the LNCs from IFA-pretreated donors failed to prevent AA. According to the T helper type 1 (Th1)/Th2 paradigm, it was suggested that the adjuvant-active vehicles such as IFA, hexadecane, squalane, methyl oleate and pristane, can affect and deviate the Th1/Th2 balance of immune responses in host. CFA could promote the propagation of Th2 cells rather than Th1 cells in these vehicle-pretreated rats through as yet undetermined mechanisms, eventually resulting in the prevention of AA. Finally, we discussed a regulatory role of adjuvant vehicles for induction and suppression of AA.
Zhang
L
L
Department of Microbiology, Saga Medical School, Nabeshima, Japan.
Mia
M Y
MY
Zheng
C L
CL
Hossain
M A
MA
Yamasaki
F
F
Tokunaga
O
O
Kohashi
O
O
D019264:Adoptive Transfer; D000473:Alkanes / Q000494:pharmacology; D000818:Animals; D001169:Arthritis, Experimental / Q000276:immunology* / Q000517:prevention & control; D003208:Concanavalin A / Q000494:pharmacology; D005260:Female; D005620:Freund's Adjuvant / Q000494:pharmacology*; D008214:Lymphocytes; D009829:Oleic Acids / Q000494:pharmacology; D014677:Pharmaceutical Vehicles / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D013185:Squalene / Q000494:pharmacology; D013729:Terpenes / Q000494:pharmacology; D018417:Th1 Cells; D018418:Th2 Cells
D000473:Alkanes; D009829:Oleic Acids; D014677:Pharmaceutical Vehicles; D013729:Terpenes; D003208:Concanavalin A; C009042:pristane; C005576:methyl oleate; D013185:Squalene; D005620:Freund's Adjuvant; C007932:n-hexadecane